1. India Stocks

  2. •

    Process industries

  3. •

    Chemicals: major diversified
Omkar Pharmachem Ltd.

Omkar Pharmachem Ltd.

BBSE:OMKARPH
7.59
INR
-0.01
(-0.13%)
0.08EPS
234.57P/E
200.20MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.07
- -
- -
- -
- -
- -
0.04
0.27
0.54
0.54
0.54
- -
- -
- -
Basic EPS, GAAP
- -
-0.06
-0.12
0.22
-0.25
-0.42
-0.26
0.22
0.18
0.2
0.19
0.2
0.12
0.08
Free Cash Flow per Basic Share
0.02
-0.05
0.34
-0.77
-0.26
-0.3
-0.21
0.02
0.19
0.27
0.28
0.24
0.23
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
9.26
9.2
9.08
9.3
9.04
8.63
8.37
8.59
8.77
8.97
9.15
9.35
36.33
- -
Tangible Book Value per Share
9.26
9.2
9.08
9.3
9.04
8.63
8.37
8.59
8.77
8.97
9.15
9.35
36.33
- -
Basic Weighted Avg Shares
10
10
10
10
10
10
10
10
10
10
10
10
10
10
Sales/Revenue/Turnover
1
- -
- -
- -
- -
- -
- -
3
5
5
5
- -
- -
- -
Operating Margin (%)
5.62
- -
- -
- -
- -
- -
-457.78
11.19
49.43
57.11
51.69
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-1
-1
2
-3
-4
-3
2
2
2
2
2
1
1
Effective Tax Rate (%)
- -
- -
- -
18.13
- -
- -
- -
- -
13.02
25.22
25.2
25.59
25.18
27.24
Profit Margin (%)
5.62
- -
- -
- -
- -
- -
-576.89
82
33.91
36.63
35.02
- -
- -
- -
Working Capital
- -
- -
-2
1
-2
-6
-9
-9
-7
-4
-2
1
3
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
93
93
92
94
91
87
84
87
88
90
92
94
366
- -
Return on Invested Capital (%)
0.04
- -
- -
2.38
- -
- -
- -
- -
2.4
2.37
2.17
2.22
0.51
- -
Return on Capital (%)
0.04
- -
- -
2.38
- -
- -
- -
- -
2.4
2.39
2.2
2.24
0.53
- -
Return on Common Equity (%)
0.04
-0.66
-1.27
2.38
-2.77
-4.72
-3.03
2.59
2.09
2.21
2.07
2.15
0.53
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
10
10
10
Market Capitalization
299
298
200

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
3
- -
Cash, Cash Equivalents & STI
- -
2
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
1
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
29.17%
59.4%
288.39%
Free Cash Flow
28.06%
159.71%
-4.63%
Net Income, GAAP
-71.07%
-9.36%
-39.37%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.05
0.09
0.08
-0.02
0.2
2026
0.03
0.05
0.03
0.01
0.12
2027
-0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
Sector
Process industries
Industry
Chemicals: major diversified
Address
Ahmedabad India
IPO Date
Nov 23, 2006
Website
omkarpharmachem.co.in
Similar Companies
Hektas Ticaret T.A.S. (BIST:HEKTS)
AARTI Industries Ltd (NSE:AARTIIND)
Aether Industries Ltd. (NSE:AETHER)
Mitsui & Co.,Ltd (TSE:8031)
Saudi Basic Industries Corp. (TADAWUL:2010)
Raghav Productivity Enhancers Ltd. (NSE:RPEL)
Business
Omkar Pharmachem Limited is an India-based company engaged in the trading, wholesale distribution, and commercial supply of pharmaceutical raw materials, active pharmaceutical ingredients, and specialty chemical intermediates. Founded in 1995 and headquartered in Ahmedabad, Gujarat, India, the company operates within the pharmaceutical and chemical trading sectors, catering to pharmaceutical formulation manufacturers, research laboratories, and industrial chemical processors. The company's product and service portfolio comprises the sourcing and wholesale distribution of active pharmaceutical ingredients (APIs) for therapeutic drug formulations; pharmaceutical intermediates utilized in medicinal synthesis; bulk drug compounds and medicinal chemical derivatives; organic and inorganic specialty chemicals; analytical grade fine chemicals; and commercial procurement and distribution services for domestic pharmaceutical formulation units. Omkar Pharmachem Limited conducts its operations primarily across the Indian domestic market, leveraging commercial supply networks to serve regional pharmaceutical and chemical manufacturing hubs. In recent developments, the company has undertaken initiatives to optimize its working capital management, streamline its wholesale distribution channels, strengthen vendor relationships for specialty chemical sourcing, enhance inventory turnover efficiency, and explore strategic commercial partnerships to expand its product offerings across domestic industrial corridors.